Android app Apple app link

Intellia Therapeutics, Inc. (NTLA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$9.74

south_east
-$0.32 (-3.13%)
Day's range
$9.59
Day's range
$10.39

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/11/2024 Oppenheimer Jay Olson $60.00 $17.16   249.65%
10/24/2024 Robert W. Baird Jack Allen $18.00 $15.85   13.56%
08/09/2024 RBC Capital Luca Issi $54.00 $22.38   141.29%
06/24/2024 Stifel Nicolaus Dae Gon Ha $80.00 $25.22   217.21%
06/24/2024 Robert W. Baird Jack Allen $24.00 $26.00   -7.67%
05/10/2024 BMO Capital Kostas Biliouris $70.00 $24.84   181.8%
06/16/2022 BMO Capital Kostas Biliouris $54.00 $41.44   30.31%
05/08/2022 Raymond James Steven Seedhouse $105.00 $47.57   120.73%
02/23/2022 RBC Capital Luca Issi $150.00 $87.46   71.51%
02/17/2022 William Blair Raju Prasad $144.00 $86.52   66.44%
02/14/2022 Truist Financial Joon Lee $160.00 $98.52   62.4%
02/02/2022 Piper Sandler Swapnil Malekar $171.00 $94.53   80.89%
02/02/2022 Wedbush David Nierengarten $108.00 $94.53   14.25%
11/15/2021 Roth Capital Anthony Butler $180.00 $137.51   30.9%
08/05/2021 Raymond James Steven Seedhouse $181.00 $167.31   8.18%
08/05/2021 Goldman Sachs Salveen Richter $252.00 $167.31   50.62%
08/04/2021 Barclays Gena Wang $207.00 $165.16   25.33%
06/21/2021 Jefferies Maury Raycroft $109.00 $78.91   38.13%

Intellia Therapeutics, Inc. FAQ's

What analysts cover Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. has been rated by research analysts at Oppenheimer, Robert W. Baird, RBC Capital, Stifel Nicolaus, BMO Capital, Cantor Fitzgerald in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.